SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-438230
Filing Date
2013-11-12
Accepted
2013-11-12 16:06:34
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d589006d10q.htm 10-Q 783394
2 EX-31.1 d589006dex311.htm EX-31.1 6719
3 EX-31.2 d589006dex312.htm EX-31.2 6691
4 EX-32 d589006dex32.htm EX-32 4317
  Complete submission text file 0001193125-13-438230.txt   8027891

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT dndn-20130930.xml EX-101.INS 1509130
6 XBRL TAXONOMY EXTENSION SCHEMA dndn-20130930.xsd EX-101.SCH 51361
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dndn-20130930_cal.xml EX-101.CAL 52234
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dndn-20130930_def.xml EX-101.DEF 128490
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dndn-20130930_lab.xml EX-101.LAB 359592
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dndn-20130930_pre.xml EX-101.PRE 299354
Mailing Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101
Business Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101 206-219-7815
DENDREON CORP (Filer) CIK: 0001107332 (see all company filings)

IRS No.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35546 | Film No.: 131210195
SIC: 2834 Pharmaceutical Preparations